[go: up one dir, main page]

EA029062B9 - Method of producing pharmaceutical composition and product therefrom - Google Patents

Method of producing pharmaceutical composition and product therefrom

Info

Publication number
EA029062B9
EA029062B9 EA201300939A EA201300939A EA029062B9 EA 029062 B9 EA029062 B9 EA 029062B9 EA 201300939 A EA201300939 A EA 201300939A EA 201300939 A EA201300939 A EA 201300939A EA 029062 B9 EA029062 B9 EA 029062B9
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical composition
product therefrom
producing pharmaceutical
dosage form
proposed
Prior art date
Application number
EA201300939A
Other languages
Russian (ru)
Other versions
EA029062B1 (en
EA201300939A1 (en
Inventor
Фернандо Энрике Прочаска
Original Assignee
Тютор С.А.С.И.Ф.И.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Тютор С.А.С.И.Ф.И.А. filed Critical Тютор С.А.С.И.Ф.И.А.
Priority to EA201300939A priority Critical patent/EA029062B9/en
Publication of EA201300939A1 publication Critical patent/EA201300939A1/en
Publication of EA029062B1 publication Critical patent/EA029062B1/en
Publication of EA029062B9 publication Critical patent/EA029062B9/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Proposed are a method of producing a pharmaceutical composition that is a solid dosage form, providing premixing an active principle, in particular a polymorphic form of imatinib mesylate, with a hydrophilic compound, and a product obtained by the proposed method. The proposed method allows to produce a solide dosage form with improved thermal stability, solubility and storage stability.
EA201300939A 2013-09-20 2013-09-20 Method of producing pharmaceutical composition and product therefrom EA029062B9 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EA201300939A EA029062B9 (en) 2013-09-20 2013-09-20 Method of producing pharmaceutical composition and product therefrom

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EA201300939A EA029062B9 (en) 2013-09-20 2013-09-20 Method of producing pharmaceutical composition and product therefrom

Publications (3)

Publication Number Publication Date
EA201300939A1 EA201300939A1 (en) 2015-03-31
EA029062B1 EA029062B1 (en) 2018-02-28
EA029062B9 true EA029062B9 (en) 2018-05-31

Family

ID=52744868

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201300939A EA029062B9 (en) 2013-09-20 2013-09-20 Method of producing pharmaceutical composition and product therefrom

Country Status (1)

Country Link
EA (1) EA029062B9 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2555804C (en) * 2004-02-11 2012-06-26 Natco Pharma Limited Polymorphic form of imatinib mesylate and a process for its preparation
ATE459341T1 (en) * 2005-06-03 2010-03-15 Elan Pharma Int Ltd NANOPARTICLE SHAPED IMATINIB MESYLATE FORMULATIONS
US20100330130A1 (en) * 2009-05-22 2010-12-30 Actavis Group Ptc Ehf Substantially pure imatinib or a pharmaceutically acceptable salt thereof

Also Published As

Publication number Publication date
EA029062B1 (en) 2018-02-28
EA201300939A1 (en) 2015-03-31

Similar Documents

Publication Publication Date Title
MX2019011926A (en) Methods useful in the synthesis of halichondrin b analogs.
UY35700A (en) NEW COMPOUNDS AND THEIR PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHYSICAL FIBROSIS
CR20140464A (en) HETEROCICLYL COMPOUNDS
SG10201808624VA (en) Polymorphs of selinexor
WO2015192834A3 (en) Method for producing a consumable provided for evaporation
BR112016008576A2 (en) STABLE AQUEOUS FORMULATIONS OF ANTIBODIES AND PHARMACEUTICAL UNIT DOSAGE FORM
EA201600124A1 (en) NEW INDOLESINE COMPOUNDS, METHOD OF THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PH12015502118A1 (en) Pyridin-4-yl derivatives
CR20120494S (en) BLISTER PACKAGING FOR PRODUCT
BR112016022394A2 (en) PHARMACEUTICALLY ACCEPTABLE COMPOSITION, COMPOSITION IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE INJECTABLE SOLUTION, USE OF THE COMPOSITION, AND METHOD FOR PREPARING THE PHARMACEUTICALLY ACCEPTABLE INJECTABLE COMPOSITION
CR20150555A (en) NEW DERIVATIVES OF PIRROLO [2,3-D] PYRIMIDINE
UY35997A (en) ISOQUINOLEINE DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PH12016502544B1 (en) Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor
EA201591150A1 (en) SOLID UNIFORM FORM WITH HIGH CONTENT OF FEXOPHENADINE AND METHOD FOR OBTAINING IT
MX385406B (en) BIOMASS FORMULATION.
PH12015502717B1 (en) Anti-fibrogenic compounds, methods and uses thereof
WO2015002755A3 (en) Compounds for the treatment of malaria
WO2015087343A3 (en) An improved process for the preparation of nilotinib and pharmaceutically acceptable salts thereof
EA029062B9 (en) Method of producing pharmaceutical composition and product therefrom
MX2016000775A (en) Pharmaceutical preparation comprising aminopyrazole derivative.
IN2013CH04314A (en)
EA201591644A1 (en) DOSAGE FORM CONTAINING CRYZOTINIB
MX2017004770A (en) Solid forms of nilotinib hydrochloride.
IN2013MU03508A (en)
MX2015011505A (en) Compounds for improved stem cell differentiation into hepatocytes.

Legal Events

Date Code Title Description
TH4A Publication of the corrected specification to eurasian patent
QB4A Registration of a licence in a contracting state